Insiders Centogene N.V.

Equities

CNTG

NL0014040206

Market Closed - Nasdaq Other stock markets 04:30:00 2024-07-12 pm EDT			5-day change	1st Jan Change
0.5151 ^USD	+3.02%		+16.54%	-57.08%

Jun. 20	Critical Path Institute and Centogene N.V. Announces the Signing of A Memorandum of Understanding to Advance Drug Development for Lysosomal Diseases	CI
May. 16	Upcoming Slew of Economic Data Buoys Exchange-Traded Funds, Equity Futures Pre-Bell Thursday	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Centogene N.V. Announces Changes to Supervisory Board	Dec. 18	CI
Flemming Ornskov Decides to Step Down from His Role as a Member of the Supervisory Board of Centogene	23-10-06	CI
Centogene N.V. Announces Resignation of Berndt Modig from Supervisory Board	23-08-18	CI
Bettina Goerner Decides to Step Down as Chief Data Officer of Centogene N.V., Effective May 26, 2023	23-05-19	CI
Centogene N.V. Appoints Ian Rentsch as Chief Commercial Officer and General Manager - Pharma, Effective March 15, 2023	23-03-09	CI
Centogene N.V. Appoints Prof. Peter Bauer, Chief Medical and Genomic Officer to its Management Board and as Managing Director of the subsidiary Centogene GmbH	23-01-30	CI
Centogene N.V. Announces Resignation of Florian Vogel as Chief Process Officer, Effective February 28, 2023	23-01-19	CI
Centogene N.V. Announces Changes to Supervisory Board	22-11-21	CI
Centogene Appoints Miguel Coego Rios as CFO	22-06-27	MT
Centogene N.V. Announces Appointment of Miguel Coego Rios as Managing Director	22-06-27	CI
Centogene N.V. Announces Resignation of Volkmar Weckesser as Chief Information Officer and Member of the Management Board	22-05-03	CI
Centogene Chief Financial Officer to Resign; Miguel Coego Rios Named as Interim CFO	22-02-08	MT
Centogene N.V. Appoints Miguel Coego Rios as Executive Vice President of Finance & Legal	22-02-08	CI
Centogene Appoints Kim Stratton as Permanent Chief Executive Officer	22-02-01	MT
Centogene Nominates Kim Stratton as Chief Executive Officer	22-02-01	CI
Centogene CEO Andrin Oswald to Take Medical Leave; Interim CEO Named	21-12-20	MT
Centogene N.V. Announces Executive Changes	21-12-20	CI
Centogene N.V. Replaces Phil Lambert with Dr. Patrice P. Denèfle as Chief Scientific Officer	21-07-27	CI
Centogene N.V. Appoints Rene Just as Managing Director	21-06-25	CI
Centogene N.V. Announces the Nomination of Rene Just as Chief Financial Officer, Effective June 1, 2021	21-05-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Centogene N.V.

Equities

CNTG

NL0014040206

Insiders

Filters